Workup for Dry Eyes
Begin with a detailed symptom assessment using validated questionnaires (OSDI or NEI-VFQ25), followed by slit-lamp examination with specific diagnostic tests including tear break-up time, ocular surface staining, and tear osmolarity or MMP-9 testing to confirm the diagnosis. 1
Initial Clinical Assessment
Symptom Evaluation
- Document specific symptoms: irritation, burning, stinging, foreign body sensation, photophobia, blurred vision, contact lens intolerance, redness, mucous discharge, eye fatigue, and diurnal fluctuation (typically worsening later in the day) 1
- Use validated questionnaires: the Ocular Surface Disease Index (OSDI) has demonstrated good specificity (0.83) and moderate sensitivity (0.60) for distinguishing dry eye from normal subjects 1
- Identify exacerbating factors: air travel, low humidity, air drafts from fans or air conditioner vents, prolonged screen time, reading, digital device use, and poorly fitted sleep apnea devices 1
Comprehensive History
- Medication review: Identify systemic medications that decrease tear production (antihistamines, decongestants, antidepressants, antihypertensics, hormonal therapies) 1
- Systemic disease screening: Ask about dry mouth, joint pain, skin rashes, thyroid symptoms, or family history of autoimmune disorders 1
- Ocular history: Previous eye surgeries (particularly LASIK or cataract surgery), contact lens wear, and prior ocular surface disease 1
- Environmental exposures: Screen time duration, occupational exposures, smoking status, and living/working environment humidity 1
Slit-Lamp Examination
Essential Findings to Document
- Tear meniscus height: Reduced height suggests aqueous deficiency 1
- Lid margin abnormalities: Meibomian gland obstruction, telangiectasia, lid margin irregularity, or signs of blepharitis 1
- Conjunctival changes: Injection, chemosis, scarring, keratinization, or mucous plaques 1
- Corneal findings: Punctate epithelial erosions, filaments, epithelial defects, basement membrane irregularities, thinning, infiltrates, ulceration, or neovascularization 1
Diagnostic Testing Algorithm
First-Tier Tests (Perform in All Suspected Cases)
- Tear break-up time (TBUT): Apply fluorescein dye and measure time until first break in tear film; less than 10 seconds is abnormal 1
- A rapid TBUT may indicate unstable tear film with normal aqueous production and minimal ocular surface staining 1
- Ocular surface staining: Use fluorescein, lissamine green, or rose bengal to assess epithelial damage; staining of inferior cornea and bulbar conjunctiva within the palpebral fissure is typical 1
Second-Tier Tests (Select Based on Clinical Presentation)
Tear osmolarity: Elevated osmolarity (>308 mOsm/L) or inter-eye differences (>8 mOsm/L) confirm diagnosis 1
Point-of-care MMP-9 test: Binary test indicating presence of inflammation; aids in diagnosis and can assess disease state changes 1
- Does not differentiate dry eye from other inflammatory ocular surface diseases 1
Schirmer test without anesthesia (Schirmer I): Measures both basic and reflex tearing; less than 5.5 mm of wetting after 5 minutes is diagnostic of aqueous tear deficiency 1
Meibomian gland assessment: Evaluate expressibility and quality of meibum secretions 1
Corneal Sensation Testing
- Assess when trigeminal nerve dysfunction is suspected (history of herpes zoster, diabetes, contact lens wear, or refractive surgery) 1
Laboratory Workup for Systemic Disease
Indications for Serologic Testing
Order laboratory tests when patients have:
- Significant dry eye with other autoimmune symptoms (particularly dry mouth) 1
- Family history of autoimmune disorders 1
- Severe dry eye in younger patients or males (atypical demographics) 1
Specific Testing by Suspected Condition
For Sjögren Syndrome (approximately 10% of clinically significant aqueous deficient dry eye cases) 1:
- Anti-Sjögren syndrome A antibody (SSA/anti-Ro)
- Anti-Sjögren syndrome B antibody (SSB/anti-La)
- Antinuclear antibody (ANA)
- Rheumatoid factor (RF)
- Salivary protein 1 (SP1)
- Carbonic anhydrase 6 (CA6)
- Parotid secretory protein (PSP) 1
For Thyroid Eye Disease:
- Antithyroid peroxidase antibody
- Antithyroglobulin antibody
- Orbital imaging (CT or MRI) if proptosis or lid retraction present 1
For Sarcoidosis:
- Serum lysozyme
- Angiotensin-converting enzyme (ACE)
- Chest CT to determine disease extent
- Consider conjunctival biopsy
- Consult pulmonology as necessary 1
For Ocular Mucous Membrane Pemphigoid:
- Conjunctival biopsy with light microscopy and immunofluorescent or immunohistochemical studies 1
Classification of Disease Severity
Mild Dry Eye
- Symptoms: Intermittent irritation, itching, soreness, ocular discomfort, burning, or intermittent blurred vision 1
- Signs: Inconsistent correlation between symptoms and clinical findings 1
Moderate Dry Eye
- Increased discomfort and frequency of symptoms
- More consistent negative effect on visual function 1
Severe Dry Eye
- Constant or potentially disabling visual symptoms
- Risk of complications: ocular surface keratinization, conjunctival fibrosis, limbal stem cell deficiency, corneal scarring, thinning, neovascularization, microbial or sterile corneal ulceration with possible perforation 1
Critical Pitfalls to Avoid
- Don't rely on a single diagnostic test: The diagnosis is difficult because of inconsistent correlation between symptoms and signs; combine at least two tests 1, 2
- Don't miss underlying systemic disease: Ophthalmologists should have a high index of suspicion for Sjögren syndrome (associated with increased lymphoma risk) and low threshold for serologic workup 1
- Don't overlook meibomian gland dysfunction: Most patients have evaporative or mixed-mechanism dry eye rather than pure aqueous deficiency 1
- Don't dismiss pediatric presentations: Children may present with chronic recurrent blepharokeratoconjunctivitis and subtle rosacea signs before cutaneous manifestations 1
- Recognize post-surgical dry eye: All patients undergoing cataract or refractive surgery should be evaluated preoperatively, as baseline parameters predict postoperative risk 1